Mercury Pharmaceuticals

We are de-risking biomedical innovations, while turning biomedical knowledge into social and economic value.

Stay Informed!

Novel AI ECG model outperforms standard triage for acute coronary occlusion

29

Oct 2025

Novel AI ECG model outperforms standard triage for acute coronary occlusion

Using artificial intelligence (AI) to analyze electrocardiograms (ECG) improved detection of severe heart attacks, including those that presented with unconventional symptoms, or atypical ECG patterns, and reduced false positives, according to a study published in JACC: Cardiovascular Interventions and simultaneously presented at TCT 2025 in San Francisco.

Standardized criteria show sustained reduction in hospital stay

29

Oct 2025

Standardized criteria show sustained reduction in hospital stay

A new approach to hospital discharges at UCLA reduced the time patients spent waiting to leave the hospital by nearly 50% for four common diagnoses and improved length of hospital stay by 2.5 days, according to a new pilot study at UCLA Health. Researchers say the standardized system could also serve as a case study for U.S. hospitals facing insufficient bed capacity and slow patient throughput.

Purdue researchers develop 30-second vaccine quality tool

29

Oct 2025

Purdue researchers develop 30-second vaccine quality tool

The outbreak of the COVID-19 pandemic demonstrated the need to rapidly develop, produce and distribute large quantities of new vaccines. A team of researchers at Purdue University and Merck & Co. Inc., known as Merck Sharp & Dohme Corp. outside of the U.S. and Canada, has now introduced a new analytical tool that could help pharmaceutical companies boost vaccine production with rapid monitoring and analysis.

How branding and peer pressure keep kids hooked on energy drinks

28

Oct 2025

How branding and peer pressure keep kids hooked on energy drinks

Children and adolescents in North East England still find energy drinks easy to access despite a voluntary UK ban, drawn by taste, price, and powerful marketing. Hydration drinks like PRIME are viewed as “healthier,” even though young consumers often misunderstand their ingredients and health impacts.

MERCURY trials

Clinical trials are very important as it allow us to evaluate the effectiveness of new drugs, new devices, preventative strategies or treatment strategies. It also enables us to discover better ways for patients' care.
- Learn more

Cancer

Our mission remains constant as we endeavor to deliver novel medicines to patients with cancer, treating solid tumors with high unmet medical needs in well-defined patient populations that are currently not well supported.
- Learn more

Neuroscience

Whether you're looking to manufacture toxicology batches or cGMP material for clinical trials, we can help you expedite molecules to clinic with full transparency.
- Learn more

Mercury Pharmaceuticals

Why Us?

Strong experience in academic research and technology transfer makes us understand your goals and motivations as a technology originator.
Our experience in drug development from discovery to clinical and commercial stages makes us an insider player within the biopharmaceutical industry.
Smart approach to project management that helps speed up development stages and decision making.
Availability of own investment up to 2m€ per project allows us to reach the next value milestone.